Literature DB >> 21989501

Evaluation of NHANES biomonitoring data for volatile organic chemicals in blood: application of chemical-specific screening criteria.

Christopher R Kirman1, Lesa L Aylward, Ben C Blount, David W Pyatt, Sean M Hays.   

Abstract

Available biomonitoring data for volatile organic chemicals (VOCs) in blood from the National Health and Nutrition Examination Survey (NHANES) (2003-2004) (CDC, 2009) were compared with recently derived screening biomonitoring equivalent (BE) values (Aylward et al., 2010). A BE is defined as the estimated concentration or range of concentrations of a chemical or its metabolites in a biological medium (blood, urine, or other medium) that is consistent with an existing health-based exposure guidance value. Blood concentrations of VOCs from the NHANES data set were compared with predicted screening BE values based upon a hazard quotient (HQ) for individual chemicals, and a hazard index (HI) approach for combined exposures. HI values for detected chemicals were generally at or below a value of 1, suggesting that the potential for deleterious effects is low. However, smoking was an important determinant of HI and HQ values. Detected levels of benzene in non-smokers were within the range of BE values corresponding to a 1 × 10(-6)-1 × 10(-4) range for upper-bound cancer risk; in smokers, levels of benzene were at the upper end of or exceeded this range. For VOCs that were not detected in the NHANES sampling, analytical detection limits were generally sufficiently sensitive to detect concentrations consistent with existing non-cancer and cancer risk-based exposure guidance values. Interpretations of measured blood concentrations of VOCs must be made with caution due to the substantial within-individual, within-day fluctuations in levels expected due to the rapid elimination of VOCs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21989501     DOI: 10.1038/jes.2011.37

Source DB:  PubMed          Journal:  J Expo Sci Environ Epidemiol        ISSN: 1559-0631            Impact factor:   5.563


  5 in total

Review 1.  The use of biomonitoring data in exposure and human health risk assessment: benzene case study.

Authors:  Scott M Arnold; Juergen Angerer; Peter J Boogaard; Michael F Hughes; Raegan B O'Lone; Steven H Robison; A Robert Schnatter
Journal:  Crit Rev Toxicol       Date:  2013-02       Impact factor: 5.635

2.  Volatile Organic Compounds in Blood as Biomarkers of Exposure to JP-8 Jet Fuel Among US Air Force Personnel.

Authors:  Alexis L Maule; Susan P Proctor; Benjamin C Blount; David M Chambers; Michael D McClean
Journal:  J Occup Environ Med       Date:  2016-01       Impact factor: 2.162

3.  Evaluation of biomonitoring data from the CDC National Exposure Report in a risk assessment context: perspectives across chemicals.

Authors:  Lesa L Aylward; Christopher R Kirman; Rita Schoeny; Christopher J Portier; Sean M Hays
Journal:  Environ Health Perspect       Date:  2012-12-11       Impact factor: 9.031

4.  Application of physiologically based pharmacokinetic models in chemical risk assessment.

Authors:  Moiz Mumtaz; Jeffrey Fisher; Benjamin Blount; Patricia Ruiz
Journal:  J Toxicol       Date:  2012-03-19

Review 5.  Metabolomics and the Multi-Omics View of Cancer.

Authors:  David Wishart
Journal:  Metabolites       Date:  2022-02-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.